Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-84.28	-7.84	49.84
Graham Fair Price	41.42	0.10	0.07
PEG	-58.61	-0.03	0.06
Price/Book	-31.34	0.43	0.63
Price/Cash Flow	65.67	-3.33	-9.70
Prices/Earnings	65.67	-2.63	-7.67
Price/Sales	-65.67	0.13	0.37
Price/FCF	65.67	-3.33	-9.70
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.02	0.02
Operating Margin	23.33	< 0.005	< 0.005
ROA	-100.00	-0.01	< 0.005
ROE	-0.02	-0.04	-100.00
ROIC	< 0.005	< 0.005	-193.32
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.99	43.96	-97.75
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.14	-0.53	53.33
EPS QOQ	-1.21	-1.00	17.05
FCF QOQ	-1.18	-1.00	15.56
Revenue QOQ	-0.04	1.00	2154.64
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-19.69	-9.84	50.00
Days Sales Outstanding (DSO)	86.81	47.19	-45.64
Inventory Turnover	-4.57	-9.14	-100.00
Debt/Capitalization	0.48	0.01	-97.56
Quick Ratio	1.23	1.41	14.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.11	0.11	< 0.005
Cash	0.10	0.12	24.34
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	-0.01	-100.00
Revenue	0.18	0.36	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.41	1.41	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.32	-18.20	76.32
Naive Interpretation	Member

06 - Financial Health · Weak

Rating